ATRA vs CE · rev $128.9M vs rev $10.28B
Atara Biotherapeutics Inc (ATRA) versus Celanese Corporation (CE) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Celanese Corporation (CE) is a chemicals company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
ATRA currently screens at market cap $87.1M. CE currently screens at market cap $5.92B.
Not investment advice. Open the ATRA and CE stock pages for the full models.
Not investment advice.